Clearline Capital LP Cytokinetics Inc Transaction History
Clearline Capital LP
- $1.53 Billion
- Q1 2025
A detailed history of Clearline Capital LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Clearline Capital LP holds 166,477 shares of CYTK stock, worth $5.77 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
166,477
Previous 166,477
-0.0%
Holding current value
$5.77 Million
Previous $7.83 Million
14.57%
% of portfolio
0.44%
Previous 1.14%
Shares
3 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$509 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$411 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$345 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$277 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$211 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.26B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...